Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00871039Phase 4Withdrawn
Phase 4, randomised, open-label trial in respiratory failure comparing Propofol with Midazolam (2 arms). Primary endpoint: Stress response and immune function at 6 months. Planned start Mar 2009; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00871039.